Fig. 4From: Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysisREACTOME pathway analysis of the altered proteins in response to IVC. a The most notable 10 of 148 REACTOME pathways of all the differentially expressed proteins. b REACTOME pathways of the decreased proteins. c the most notable 10 of 139 REACTOME pathways of the increased proteinsBack to article page